Skip to content

HR 9421 · 119th Congress

To prohibit a REMS-certified provider from prescribing mifepristone without an in-person visit and a medical license in the State in which the patient resides, and for other purposes.

Introduced Jun 24, 2026Last action Jun 24, 2026Congress.gov →

Latest action

Referred to the House Committee on Energy and Commerce.

Sponsor

Sheri BiggsRepublican · SC-3Profile →

Cosponsors (2)

2 R